56.47
0.65 (1.16%)
| Previous Close | 55.82 |
| Open | 56.05 |
| Volume | 20,497 |
| Avg. Volume (3M) | 43,273 |
| Market Cap | 715,666,944 |
| Price / Earnings (TTM) | 38.68 |
| Price / Earnings (Forward) | 32.47 |
| Price / Sales | 9.17 |
| Price / Book | 7.78 |
| 52 Weeks Range | |
| Earnings Date | 6 Feb 2025 - 10 Feb 2025 |
| TTM Dividend Yield | 1.91% |
| Profit Margin | 26.12% |
| Operating Margin (TTM) | 31.59% |
| Diluted EPS (TTM) | 1.46 |
| Quarterly Revenue Growth (YOY) | 11.00% |
| Quarterly Earnings Growth (YOY) | -0.30% |
| Total Debt/Equity (MRQ) | 0.32% |
| Current Ratio (MRQ) | 9.21 |
| Operating Cash Flow (TTM) | 23.55 M |
| Levered Free Cash Flow (TTM) | 13.14 M |
| Return on Assets (TTM) | 14.67% |
| Return on Equity (TTM) | 23.58% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | iRadimed Corporation | Bearish | Bullish |
Stockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | -3.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.5 |
| Average | -2.00 |
|
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 36.97% |
| % Held by Institutions | 56.53% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rk Capital Management, Llc | 30 Jun 2024 | 170,084 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Nov 2024 | Announcement | Sidoti Events, LLC's Virtual November Micro-Cap Conference |
| 04 Nov 2024 | Announcement | IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024 |
| 31 Oct 2024 | Announcement | IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share |
| 24 Oct 2024 | Announcement | IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st |
| 03 Oct 2024 | Announcement | IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference |
| 10 Sep 2024 | Announcement | IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference |
| TTM Dividend Yield | 1.91% |
| 2Y Average Dividend Yield | 2.87% |
| Payout Ratio | 30.82% |
| Expected Next Dividend Payment | May 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 15 Nov 2024 | 30 Oct 2024 | 25 Nov 2024 | 0.15 Cash |
| 20 Aug 2024 | 31 Jul 2024 | 30 Aug 2024 | 0.15 Cash |
| 17 May 2024 | 02 May 2024 | 30 May 2024 | 0.15 Cash |
| 21 Dec 2023 | 07 Dec 2023 | 12 Jan 2024 | 0.63 Cash |
| 10 Feb 2023 | 01 Feb 2023 | 21 Feb 2023 | 1.05 Cash |
| 16 Feb 2022 | 07 Feb 2022 | 24 Feb 2022 | 1 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.08 | 4 | 1.91 |
| 2023 | 1.05 | 1 | 2.21 |
| 2022 | 1.00 | 1 | 3.54 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |